Over 10 years experience of Traceability Solutions
By pharmatrax
Category: Technoloy
No Comments Such technologies, such as RFID and IIoT, help to address cold chain inefficiencies by providing increased visibility into the locations, properties, and conditions of sensitive…
By pharmatrax
Category: Technoloy
No Comments Paul Tunnah runs through the six key aspects of digital health and how businesses can harness them. It’s that time of year again – the leaves…
By pharmatrax
Category: Technoloy
No Comments Four big pharma experts explain the challenges companies face in adopting digital tech and what trends are likely to drive digital commercial strategies in the…
By pharmatrax
Category: Technoloy
No Comments SilverCloud Health and Microsoft have embarked on a research collaboration to further enhance the digital mental health company’s online offering with artificial intelligence (AI). SilverCloud…
By pharmatrax
Category: Technoloy
No Comments The healthcare sector has been perhaps the slowest of all industries to embrace digitisation — and in fewer countries is this more evident than in…
By pharmatrax
Category: Technoloy
No Comments At the HIMSS Connected Health Conference, Bob Coughlin, president and CEO of Mass Biotech Council, offers his expert view of how these two areas of…
By pharmatrax
Category: Technoloy
No Comments The advances in Artificial intelligence (AI) have effectively proliferated into numerous sectors, for example, computer vision, speech recognition and natural language processing. Artificial intelligence is…
By pharmatrax
Category: Technoloy
No Comments A study that identified 12 novel compounds that may prove valuable against new drug targets for leishmaniasis and Chagas disease was not without complication. Here,…
By pharmatrax
Category: Technoloy
No Comments The identification and synthesis of molecules for new medicines could soon be undertaken in a lab where decisions are made by artificial intelligence, an advance…
By pharmatrax
Category: Technoloy
No Comments As precision medicine hones its skills and attempts to become even more personalized, pharma companies and clinical trial designs must embrace new strategies. Be sure…